Canndoc (INCR) Company Cash Funds

InterCure Ltd. (INCR) dominates foreign medical cannabis markets through unique licenses and its pharmacy network. The cash volume history demonstrates the impact of geopolitical instability and regulatory pressure on liquidity. High compliance costs limit profit growth, while 0.01 determines the current status of the cash reserve parameter, confirming the company's ability to withstand temporary cash flow gaps.
Analytical breakdowns for InterCure (INCR)

This metric measures the volume of liquid reserves, determining the business's ability to cover liabilities and fund growth without incurring external debt. An analysis of current cash holdings allows investors to assess the financial stability of InterCure Ltd. (INCR) as it scales its network of specialized pharmacies and supports exclusive contracts with global medical cannabis producers.